Squarcialupi Lucia, Betti Marco, Catarzi Daniela, Varano Flavia, Falsini Matteo, Ravani Annalisa, Pasquini Silvia, Vincenzi Fabrizio, Salmaso Veronica, Sturlese Mattia, Varani Katia, Moro Stefano, Colotta Vittoria
a Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica , Università di Firenze , Sesto Fiorentino , Italy.
b Dipartimento di Scienze Mediche, Sezione di Farmacologia , Università di Ferrara , Ferrara , Italy.
J Enzyme Inhib Med Chem. 2017 Dec;32(1):248-263. doi: 10.1080/14756366.2016.1247060.
New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A and/or A receptor subtypes. On the whole, the novel derivatives 1-24 shared scarce or no affinities for the off-target hA and hA ARs. The 5-(4-hydroxyphenethylamino)- derivative 12 showed both good affinity (K = 150 nM) and the best selectivity for the hA AR while the 5-benzylamino-substituted 5 displayed the best combined hA (K = 123 nM) and A AR affinity (K = 25 nM). The 5-phenethylamino moiety (compound 6) achieved nanomolar affinity (K = 11 nM) and good selectivity for the hA AR. The 5-(N-substituted-piperazin-1-yl) derivatives 15-24 bind the hA AR subtype with affinities falling in the high nanomolar range. A structure-based molecular modeling study was conducted to rationalize the experimental binding data from a molecular point of view using both molecular docking studies and Interaction Energy Fingerprints (IEFs) analysis.[Formula: see text].
合成了在5-位被芳基(烷基)氨基和4-取代哌嗪-1-基部分取代的新型7-氨基-2-苯基吡唑并[4,3-d]嘧啶衍生物,旨在靶向人(h)腺苷A和/或A受体亚型。总体而言,新型衍生物1-24对脱靶hA和hA ARs的亲和力很低或没有亲和力。5-(4-羟基苯乙氨基)衍生物12对hA AR表现出良好的亲和力(K = 150 nM)和最佳选择性,而5-苄基氨基取代的化合物5对hA(K = 123 nM)和A AR亲和力(K = 25 nM)的综合表现最佳。5-苯乙氨基部分(化合物6)对hA AR实现了纳摩尔级亲和力(K = 11 nM)和良好的选择性。5-(N-取代哌嗪-1-基)衍生物15-24以高纳摩尔范围内的亲和力与hA AR亚型结合。进行了基于结构的分子建模研究,从分子角度使用分子对接研究和相互作用能指纹(IEF)分析来合理化实验结合数据。[公式:见正文]